Closed
Sale
Calculated transaction value
$352.62K

Moat Ross Chief Operating Officer

Transaction date Oct 30, 2026
Public filing date Nov 3, 2026
Filing lag Filed 4 days later

KNSA daily price context

Close on/before transaction
$92.24 Oct 30, 2026
First close after public filing
$96.12 Nov 4, 2026
Return after filing · so far
-2.35% Through Nov 6, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Class A Ordinary Share
Quantity / price
3,672 shares @ $96.03
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001857177-26-000010
Filing cohort

Transactions in this filing

Showing 15 of 29
Trades
29
Issuers
1
Estimated value
$11.16M
Buys / sales
0 / 11
Transactions reported in the same official filing
Issuer Transaction Traded Value
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 2, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 2, 2026 $1.08M
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 2, 2026 $143.36K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 2, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 2, 2026 $169.98K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 2, 2026 $267.81K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 2, 2026 $822.19K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Nov 2, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 2, 2026 $609.51K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Nov 2, 2026 $67.9K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $233.75K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $3.48M
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Oct 30, 2026 $173.35K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $792.17K
Kiniksa Pharmaceuticals International, Plc KNSA Sale Oct 30, 2026 $596.29K